{
    "symbol": "NVO",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-03 20:50:28",
    "content": " Please turn to the next slide. Please turn to the next slide. Please turn to the next slide. Please turn to the next slide. Please turn to the next slide. Please turn to the next slide. So we've seen that the whole connotation around how important it is to also treat obesity and also treat overweight in people with diabetes has simply does increase -- and this, of course, has been underlined and we see that effectively by the growth, both in the diabetes segment and the strong unmet need in obesity and the demand for the go \u00e2\u0080\u0093 having said that, it's of course also important to us to just underline that we promote in each segment, the benefit of the Wegovy and of course, Ozempic in the diabetes segment and hope to cater for each of those two groups of patients."
}